Life Sciences & Chemistry

Start-up = challenge? Let’s tackle it together! 

Are you a founder in the field of life science and chemistry and on the lookout for financing? At HTGF, we not only offer you investment know-how, but also understand your specific needs and provide you with the right expertise to support your business ideas. We leverage our tailored network to help you achieve success.

Our Life Sciences & Chemistry team has the required start-up spirit! We have both entrepreneurial expertise and an understanding of science, medicine and practical applications. Having invested in over 200 life science and chemical companies since 2005, we know what really matters.

With our expertise and passion, we are at your side as a sparring partner from seed to exit – whether it be in the field of drug development and biotech, medtech and diagnostics, digital health, R&D tools or chemistry.

 Many steps must be taken to become a successful start-up

The right tools

We offer you the right tools to meet your individual challenges as a founder of a life sciences and chemical start-up:

We help you get started

  • Fast and flexible seed financing
  • Matching with co-investors from our international network
  • Communication on an equal footing
  • Inspiration and knowledge transfer

Let’s develop and grow together

  • Support in the acquisition of follow-up financing
  • Exchanges with founders and our partners from research, industry and SMEs
  • Close connection with cooperation partners

A shared path – from seed to exit

  • Support in finding the most suitable M&A advisors
  • Support in negotiations and due diligence
  • Assistance with company valuations and incentives
  • Transaction security from trade sale to IPO
  • Access to the HTGF network with many potential buyers

Who we are

What you can expect from us

  • From the very early stage to the exit, we support you as partners with our know-how and understanding of your needs.
  • We have an entrepreneurial spirit – many of us have founded our own companies and we have the necessary appetite for risk
  • We understand how financing works and can call on our network
  • We have backgrounds as scientists and know the pitfalls: manufacturing/CMC, regulatory affairs, market access, team growth, business development, etc.

The areas we invest in include:

  Pharma/biotech

  Medtech

  R&D tools

  Diagnostics

  Digital health

  Chemistry

Our Life Sciences & Chemistry Portfolio 

Let’s turn ideas into reality!

Societal challenges, such as diseases or advancing climate change, require innovative solutions. And this is why pioneering start-ups in the fields of life sciences and healthcare, chemistry, food and agricultural technology, and new materials are playing a crucial role.

Germany has the platform to continue launching successful high-tech start-ups:

  • Top-class research at universities and institutes
  • Close cooperation between industry and consumers
  • Transfer-enabling support

With your innovative start-up ideas, we can create sustainable and disruptive solutions together – what are we waiting for?

Looking to start a business? Contact our team here.

Is your pitch deck complete? Upload it here!

Topics that might interest you

Press
20. February 2024

Altavo concludes Series A for the development of its Artificial Voice

February 20, 2024 – Altavo, a startup in AI-based voice rehabilitation founded in 2021, successfully closed its Series A financing round on February 1, 2024. A European consortium led by OCCIDENT is investing € 5.0m in the development of Altavo’s novel Artificial Voice. Altavo’s Artificial Voice is a medical device designed to help voiceless people, for example after laryngectomy or during mechanical ventilation, regain their own, natural sounding voice. The proprietary “sil
 
Press
1. February 2024

Fresh Growth Capital: Innerspace secures € 5.7 Million for Further Expansion to the USA

Financing round secures Tyrolean start-up €5.7 million for continued growth   Cooperation agreement with global industry association “PDA”  Innsbruck, 1 February 2024. The Innsbruck-based tech start-up Innerspace, which enables risk assessment of production processes and effective training of cleanroom personnel for leading pharmaceutical companies using software and Virtual Reality (VR), can advance its growth trajectory after a highly succes
 
Press
31. January 2024

Breakthrough for an Alternative to Crude Oil & Palm Oil: COLIPI Receives €1.8 Million Seed Funding for Further Development of CO2-Neutral Climate OilTM

The global annual demand for oil is staggering, with 4400 million tons of fossil oil and 210 million tons of vegetable oil, often sourced from palms. It is increasing, exacerbating the threat of global warming that poses a significant risk to humanity The Hamburg-based startup COLIPI addresses this challenge with a patented Carbon Capturing & Biotransformation technology that will convert CO2 into Climate Oil. This Climate Oil is intended to have broad applications in the cosmetics a
 
Press
RAYDIAX_Founders
26. October 2023

RAYDIAX secures €3.5 million in fresh capital to develop its therapy assistance computed tomography system in the fight against cancer

RAYDIAX, a Magdeburg spin-off of the STIMULATE research campus, secures a total of €3.5 million in seed funding and grants The capital will be used to advance the development of RAYDIAX’s assistance system for image-guided, minimally invasive cancer interventions up to the pre-clinical prototype and to accelerate market development in Europe and the US Investors in the seed round include High-Tech Gründerfonds (HTGF), bmp Ventures with the IBG funds and experienced business a
 
Press
14. July 2023

Pioneering research projects at the 8th Life Science Pitch Day at the IZB

A total of sixteen teams presented their innovative ideas to more than 50 investors at the Munich start-up center. Investors at the 8th Life Science Pitch Day (Photo: Dominik Gierke / IZB) Martinsried near Munich, July 14, 2023 – On July 13, 2023, the Munich Innovation and Start-up Center for Biotechnology (IZB) organized the 8th Life Science Pitch Day in cooperation with High-Tech Gründerfonds (HTGF), Leaps by Bayer, and Boehringer Ingelheim, which brought together sixteen biotech
 
Blog
Dräger GWA Hygiene BB
18. May 2022

GWA Hygiene and Dräger: From collaboration to investment

How does a company specialized in medical and safety technology with a more than 130-year history end up getting together with a six-year-old start-up? Common goals, collaboration on an equal footing and good partners are key aspects in this regard. That is at least according to Jens Altmann, President Business Unit Data Business at Dräger, and Tobias Gebhardt, CEO at GWA Hygiene. Dräger, a global corporation, recently invested in High-Tech Gründerfonds (HTGF) portfolio company GWA Hygien